New Haven, CTNCT07800520Now EnrollingIRB Ready

Opioid Use Disorder Clinical Trial in New Haven, CT

Access cutting-edge opioid use disorder treatment through this phase 1 clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this New Haven location

Preparing your pre-screening questions…

Expert Care in New Haven

Access opioid use disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related opioid use disorder treatment provided free

Apply for This New Haven Location

Check if you qualify for this opioid use disorder clinical trial in New Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Haven site if eligible
  4. 4Begin participation

About This Opioid Use Disorder Study in New Haven

The goals of this sub-study is to assess CB1R availability in early abstinent individuals with OUD (following opioid agonist therapy - OAT stabilization) and in matched healthy controls.

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

Normal screening bloodwork.
Adequate arterial access for placement of an arterial line and blood sampling per study protocol. OUD Participants:
Diagnosis of opioid use disorder (OUD) according to DSM-5 criteria.
Actively seeking treatment for OUD.
Willingness to initiate opioid agonist therapy (OAT) with buprenorphine. Healthy Controls:
Good general physical health.
No current or past diagnosis of any psychiatric or substance use disorders.

Exclusion Criteria

Any current major medical condition that, in the opinion of the Principal Investigator, poses a risk for PET procedures.
Prior participation in research studies within the past year that would result in cumulative radiation exposure exceeding annual limits.
Presence of ferromagnetic metal in the body, pacemaker, or other contraindications to MRI.
Positive pregnancy test or current lactation.
History of neurological conditions, including stroke or seizure disorders.
Hematocrit values lower than 30 OUD Participants
Current or past diagnosis of a serious psychiatric disorder.
Current diagnosis of any substance use disorder other than nicotine or opioids.
Use of any substances within the past 30 days.
Current use of SSRIs or benzodiazepines or use within the past 30 days.
Previous enrollment in the main study. Healthy Controls:
Current or past diagnosis of any psychiatric disorder.
Current diagnosis of any substance use disorder (excluding nicotine).
Use of any substances within the past 30 days.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Haven?

Yes, this clinical trial (NCT07800520) has an active research site in New Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Opioid Use Disorder Treatment Options in New Haven, CT

If you're searching for opioid use disorder treatment options in New Haven, CT, this clinical trial (NCT07800520) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Haven research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced opioid use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all opioid use disorder clinical trials near you to find additional studies recruiting in your area.

More Substance Use Disorder Trials in New Haven, CT

See all substance use disorder clinical trials recruiting in New Haven — not just this study.

Browse Substance Use Disorder Trials in New Haven →

Browse More Trials by Condition

Substance Use Disorder TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in New Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Haven, CT